There have been all sorts of studies done on the use of Viagra to treat sexual dysfunction in female patients. However, the Food and Drug Administration (FDA) in the United States has only approved addyi as a treatment for sexual dysfunction in women. In point of fact, for a considerable amount of time there was not a single drug that had been granted approval by the FDA for the purpose of treating issues related to sexual arousal or sexual desire in women.
Although a number of drugs, including the most well-known one, Viagra, are available to increase sexual function in males, flibanserin (addyi) is the first prescription to be licenced for improving sexual function in women. The following is some pertinent information on flibanserin.
The Food and Drug Administration (FDA) granted approval for the drugflibanserin (Addyi) in 2015 for the treatment of female sexual interest/arousal disorder (FSIAD) in premenopausal women. This condition is similar to erectile dysfunction in men. Hypoactive sexual desire disorder, or HSDD, is another name for this condition.
How to obtain Addyi
Addyi can only be obtained through prescription of select doctors and pharmacies. As part of a deal between the company and the FDA, it can only be prescribed by medical professionals who have been given approval. For a prescriber to be in compliance with certain FDA criteria, the manufacturer must first certify them. It is only to be taken once each day, before going to bed.
How Addyi works for women
Addyi It is believed that flibanserin works by stimulating the release of the neurotransmitter hormones dopamine and norepinephrine, while simultaneously inhibiting the release of serotonin in the region of the brain that controls sexual behaviour.The levels of serotonin in the brain are lowered while dopamine and norepinephrine (responsible for sexual excitation) are increased after taking Addyi.Flibanserincan be used on a daily basis by women. Only premenopausal women can use flibanserin because it is only approved for them. The benefits are not particularly significant; nonetheless, there is some evidence that it can marginally improve sexual satisfaction for some women.
Criticisms associated with Addyi
There are some risks associated with Addyi. The FDA first turned down flibanserin for clearance not once but twice over the course of several years. This is due to the fact that it was believed that the adverse effects, which included low blood pressure, nausea, and fainting, were too severe in comparison to the marginal improvement in sexual function.
Additionally, consuming alcohol or using birth control pills while using this medication can make the negative effects even more severe. The manufacturer of the medication provided additional vital information during the most recent review conducted by the FDA. These data demonstrated that the medication does not impair a person’s ability to drive and affirmed that the adverse effects were exacerbated when flibanserin was combined with alcohol.
Variables that affect women’s sexual desire
There are many different variables that can influence a woman’s sexual desire. Take, for instance:
- Many women report that the pressures and demands of their daily lives have a negative impact on their desire to have sexual encounters.
- The beginning or the end of a romantic relationship, as well as significant life transitions like pregnancy or menopause, may correspond with peaks and valleys in a person’s sexual desire.
- Orgasm can be difficult to obtain for some women, which can build to fears or fixations that might ultimately result in a lack of interest in sexual activity.
- A feeling of intimacy between two people, as well as shared memories from the past, are frequently at the root of sexual desire.